Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Mitochondrial Membranes

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Author Correction: Disease exacerbation in human DMD MYOrganoids enables gene therapy evaluation and unveils persistence of fibrotic activity.

NPJ Regenerative medicine·2026

Same author

CRISPR-Cas9-mediated upregulation of utrophin ameliorates Duchenne muscular dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.

JCI insight·2026

Same author

Muscle meets Lysosomes: emerging strategies in muscular dystrophy.

Autophagy·2026

Same author

A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions.

Disease models & mechanisms·2026

Same author

Disease exacerbation in human DMD MYOrganoids enables gene therapy evaluation and unveils persistence of fibrotic activity.

NPJ Regenerative medicine·2026

Same journal

Many excellent and one bad news regarding the European Journal of Translational Myology and the 2027 Padua Days on Muscle and Mobility Medicine.

European journal of translational myology·2026

Same journal

Clinical efficacy of ramp lesion treatment: a systematic review and meta analysis study.

European journal of translational myology·2026

Same journal

Acute beetroot juice supplementation improves selected physical performance parameters, but not cardiovascular responses in healthy older women: a randomized clinical trial.

European journal of translational myology·2026

Same journal

Acute and chronic kidney injury following COVID-19 infection and vaccination: a narrative review.

European journal of translational myology·2026

Same journal

Early rehabilitation after total hip or knee joint replacement: a narrative review.

European journal of translational myology·2026

Same journal

Risk factors and critical thresholds for glucocorticoid-induced ocular adverse reactions in children: implications for muscle and neuromuscular disease management.

European journal of translational myology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 19, 2025

Assessing Functional Performance in the Mdx Mouse Model

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy.

Ai Vu Hong¹, Mathilde Sanson², Isabelle Richard³

¹Genethon, Evry, France; Université Paris-Saclay, Univ Evry, Inserm, Généthon, Integrare research unit UMR-S951, Evry. avuhong@genethon.fr.

European Journal of Translational Myology

|September 17, 2021

Summary

This summary is machine-generated.

Researchers found a new signaling pathway involving miR-379 that impacts mitochondrial function in Duchenne muscular dystrophy (DMD). This pathway may explain how glucocorticoid treatment improves mitochondrial ATP synthesis in DMD patients.

More Related Videos

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

Related Experiment Videos

Last Updated: Oct 19, 2025

Assessing Functional Performance in the Mdx Mouse Model

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

Area of Science:

Biochemistry
Molecular Biology
Genetics

Background:

Mitochondrial dysfunction is a key feature of Duchenne muscular dystrophy (DMD).
Specific molecular pathways linking mitochondrial dysfunction to DMD pathogenesis are not fully understood.

Purpose of the Study:

To elucidate the role of miR-379 in mitochondrial dysfunction in DMD.
To investigate the signaling cascade involving miR-379, EIF4G2, and DAPIT in skeletal muscle.
To understand how glucocorticoid treatment may restore mitochondrial function in DMD.

Main Methods:

Quantification of miR-379 expression in serum and muscle of DMD models and patients.
Identification of EIF4G2 as a direct target of miR-379.
Analysis of EIF4G2 and DAPIT (ATP synthase subunit) expression and translational regulation.
Assessment of mitochondrial oxidative phosphorylation (OxPhos) and ATP synthesis.

Main Results:

miR-379 is upregulated in DMD serum and muscles.
Glucocorticoid treatment normalized miR-379 expression in DMD patients.
EIF4G2, a promoter of mitochondrial OxPhos, is a translational target of miR-379.
DAPIT, a mitochondrial ATP synthase subunit, is a translational target of EIF4G2.
A signaling cascade (miR-379/EIF4G2/DAPIT) was identified, potentially linking glucocorticoid treatment to restored ATP synthesis.

Conclusions:

The miR-379/EIF4G2/DAPIT pathway is implicated in mitochondrial dysfunction in DMD.
This pathway offers a molecular explanation for the beneficial effects of glucocorticoids on mitochondrial ATP synthesis in DMD.
An updated model of mitochondrial dysfunction in DMD is proposed based on these findings.